Ursprung des Netzwerks ersten Grades von Stephan Jenn
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
NovAliX SAS
 NovAliX SAS BiotechnologyHealth Technology NovAliX SAS operates as a drug discovery-focused contract research organization. It offers drug discovery services in the fields of chemistry, collaborative models, biophysics and biology. The company was founded by Stephan Jenn and Jean-Paul Renaud in 2002 and is headquartered in Illkirch, France.
2
| Holding Company | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stephan Jenn
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Urania Therapeutics SAS
 Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Biotechnology | Director/Board Member Founder |
Statistik
International
| Frankreich | 2 |
Sektoral
| Health Technology | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 2 |
| Founder | 2 |
| Chief Executive Officer | 1 |
| President | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Denis Zeyer | 2 |
| Jean-Paul Renaud | 2 |
- Börse
- Insiders
- Stephan Jenn
- Unternehmensverbindungen
